JP7694379B2 - 酸化セリウムのナノ粒子、分散体、酸化剤、抗酸化剤および酸化セリウムのナノ粒子の製造方法、分散体の製造方法、酸化剤の製造方法ならびに抗酸化剤の製造方法 - Google Patents

酸化セリウムのナノ粒子、分散体、酸化剤、抗酸化剤および酸化セリウムのナノ粒子の製造方法、分散体の製造方法、酸化剤の製造方法ならびに抗酸化剤の製造方法 Download PDF

Info

Publication number
JP7694379B2
JP7694379B2 JP2021500751A JP2021500751A JP7694379B2 JP 7694379 B2 JP7694379 B2 JP 7694379B2 JP 2021500751 A JP2021500751 A JP 2021500751A JP 2021500751 A JP2021500751 A JP 2021500751A JP 7694379 B2 JP7694379 B2 JP 7694379B2
Authority
JP
Japan
Prior art keywords
cerium oxide
oxide nanoparticles
dispersion
producing
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021500751A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021132628A5 (https=
JPWO2021132628A1 (https=
Inventor
翔太 関口
崇光 本白水
正照 伊藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Publication of JPWO2021132628A1 publication Critical patent/JPWO2021132628A1/ja
Publication of JPWO2021132628A5 publication Critical patent/JPWO2021132628A5/ja
Application granted granted Critical
Publication of JP7694379B2 publication Critical patent/JP7694379B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00Treatment of water, waste water, or sewage
    • C02F1/72Treatment of water, waste water, or sewage by oxidation
    • C02F1/725Treatment of water, waste water, or sewage by oxidation by catalytic oxidation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/244Lanthanides; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08Materials for coatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08Materials for coatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01FCOMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F17/00Compounds of rare earth metals
    • C01F17/20Compounds containing only rare earth metals as the metal element
    • C01F17/206Compounds containing only rare earth metals as the metal element oxide or hydroxide being the only anion
    • C01F17/224Oxides or hydroxides of lanthanides
    • C01F17/235Cerium oxides or hydroxides
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00Treatment of water, waste water, or sewage
    • C02F1/72Treatment of water, waste water, or sewage by oxidation
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K15/00Anti-oxidant compositions; Compositions inhibiting chemical change
    • C09K15/02Anti-oxidant compositions; Compositions inhibiting chemical change containing inorganic compounds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K15/00Anti-oxidant compositions; Compositions inhibiting chemical change
    • C09K15/04Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds
    • C09K15/30Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds containing heterocyclic ring with at least one nitrogen atom as ring member
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K15/00Anti-oxidant compositions; Compositions inhibiting chemical change
    • C09K15/04Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds
    • C09K15/32Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds containing two or more of boron, silicon, phosphorus, selenium, tellurium or a metal
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00Crystal-structural characteristics
    • C01P2002/70Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00Particle morphology
    • C01P2004/60Particles characterised by their size
    • C01P2004/62Submicrometer sized, i.e. from 0.1-1 micrometer
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00Particle morphology
    • C01P2004/60Particles characterised by their size
    • C01P2004/64Nanometer sized, i.e. from 1-100 nanometer
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2101/00Nature of the contaminant
    • C02F2101/30Organic compounds
    • C02F2101/308Dyes; Colorants; Fluorescent agents
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2103/00Nature of the water, waste water, sewage or sludge to be treated
    • C02F2103/42Nature of the water, waste water, sewage or sludge to be treated from bathing facilities, e.g. swimming pools
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2303/00Specific treatment goals
    • C02F2303/04Disinfection
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2305/00Use of specific compounds during water treatment
    • C02F2305/08Nanoparticles or nanotubes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Materials Engineering (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Environmental & Geological Engineering (AREA)
  • Geology (AREA)
  • Water Supply & Treatment (AREA)
  • Hydrology & Water Resources (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
JP2021500751A 2019-12-26 2020-12-25 酸化セリウムのナノ粒子、分散体、酸化剤、抗酸化剤および酸化セリウムのナノ粒子の製造方法、分散体の製造方法、酸化剤の製造方法ならびに抗酸化剤の製造方法 Active JP7694379B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019236819 2019-12-26
JP2019236819 2019-12-26
PCT/JP2020/048918 WO2021132628A1 (ja) 2019-12-26 2020-12-25 酸化セリウムのナノ粒子、分散体、酸化剤、抗酸化剤および酸化セリウムのナノ粒子の製造方法

Publications (3)

Publication Number Publication Date
JPWO2021132628A1 JPWO2021132628A1 (https=) 2021-07-01
JPWO2021132628A5 JPWO2021132628A5 (https=) 2023-11-16
JP7694379B2 true JP7694379B2 (ja) 2025-06-18

Family

ID=76574446

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021500751A Active JP7694379B2 (ja) 2019-12-26 2020-12-25 酸化セリウムのナノ粒子、分散体、酸化剤、抗酸化剤および酸化セリウムのナノ粒子の製造方法、分散体の製造方法、酸化剤の製造方法ならびに抗酸化剤の製造方法

Country Status (4)

Country Link
US (1) US12291461B2 (https=)
JP (1) JP7694379B2 (https=)
CN (1) CN114901594B (https=)
WO (1) WO2021132628A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118019715A (zh) * 2021-09-29 2024-05-10 东丽株式会社 氧化铈的纳米粒子、分散液、抗病毒剂、抗菌剂、树脂组合物、树脂制品、纤维材料、纤维制品和制造氧化铈的纳米粒子的方法
US20250000097A1 (en) 2021-09-29 2025-01-02 Toray Industries, Inc. Cerium oxide nanoparticle, dispersion solution, antiviral agent, antibacterial agent, resin composition, resin product, fiber material, fiber product, and method of producing cerium oxide nanoparticle

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100998335A (zh) 2006-12-29 2007-07-18 上海师范大学 一种核壳结构的稀土纳米抗菌剂及其制备方法和应用
JP2016514163A (ja) 2013-03-14 2016-05-19 ペロキシウム・インコーポレイテッド,デラウェア・シー・コーポレーション ナノカプセル化およびコーティングによる療法用CeO2粒子の生体分布および組織ターゲティング特性を増強する方法
JP2018508569A (ja) 2015-02-06 2018-03-29 ユニティ バイオテクノロジー インコーポレイテッド 老化関連状態の治療における化合物および使用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101356870B1 (ko) * 2005-10-08 2014-01-29 재단법인서울대학교산학협력재단 세륨 산화물 나노 입자 제조 방법
WO2007043774A1 (en) 2005-10-08 2007-04-19 Seoul National University Industry Foundation Process for producing cerium oxide nanocrystals
US7504356B1 (en) 2006-02-17 2009-03-17 University Of Central Florida Research Foundation, Inc. Nanoparticles of cerium oxide having superoxide dismutase activity
US8679344B2 (en) 2008-12-17 2014-03-25 Cerion Technology, Inc. Process for solvent shifting a nanoparticle dispersion
CN102281945A (zh) * 2008-12-17 2011-12-14 丝润技术有限公司 包含晶格经改造的二氧化铈纳米颗粒的燃料添加剂
JP2012087213A (ja) * 2010-10-19 2012-05-10 Nippon Parkerizing Co Ltd 金属材用親水性皮膜、親水化処理剤、及び親水化処理方法
CN102285678B (zh) * 2011-06-09 2013-02-06 北京大学 一种氧化铈纳米颗粒的制备方法以及其抗氧化应用
US20130195927A1 (en) * 2011-12-06 2013-08-01 University Of Central Florida Research Foundation Inc. Cerium oxide nanoparticles and associated methods for promoting wound healing
KR20130114469A (ko) 2012-04-09 2013-10-17 서울대학교산학협력단 세리아 나노복합체와 이를 포함하는 약학 조성물 및 이들의 제조 방법
US10182994B2 (en) 2014-06-10 2019-01-22 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Nanoparticulate complex of nicotine and cerium oxide and use thereof
JP2018508568A (ja) 2015-01-20 2018-03-29 セリオン,リミティド ライアビリティ カンパニー カタラーゼ様活性を有するeddsでキレート化されたナノセリア

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100998335A (zh) 2006-12-29 2007-07-18 上海师范大学 一种核壳结构的稀土纳米抗菌剂及其制备方法和应用
JP2016514163A (ja) 2013-03-14 2016-05-19 ペロキシウム・インコーポレイテッド,デラウェア・シー・コーポレーション ナノカプセル化およびコーティングによる療法用CeO2粒子の生体分布および組織ターゲティング特性を増強する方法
JP2018508569A (ja) 2015-02-06 2018-03-29 ユニティ バイオテクノロジー インコーポレイテッド 老化関連状態の治療における化合物および使用

Also Published As

Publication number Publication date
CN114901594A (zh) 2022-08-12
US20230030648A1 (en) 2023-02-02
WO2021132628A1 (ja) 2021-07-01
US12291461B2 (en) 2025-05-06
JPWO2021132628A1 (https=) 2021-07-01
CN114901594B (zh) 2024-09-10

Similar Documents

Publication Publication Date Title
JP7694380B2 (ja) 酸化セリウムのナノ粒子、分散体、酸化剤、抗酸化剤および酸化セリウムのナノ粒子の製造方法、分散体の製造方法、酸化剤の製造方法ならびに抗酸化剤の製造方法
JP7508780B2 (ja) 酸化セリウムのナノ粒子、酸化セリウムのナノ粒子の製造方法、ポリペプチドの分解方法、酸化酵素代替物、漂白剤、消毒剤、抗酸化酵素代替物、ラジカル消去剤、抗カビ剤および抗ウイルス剤
JP7694379B2 (ja) 酸化セリウムのナノ粒子、分散体、酸化剤、抗酸化剤および酸化セリウムのナノ粒子の製造方法、分散体の製造方法、酸化剤の製造方法ならびに抗酸化剤の製造方法
EP3295792B1 (en) Antibacterial solution, antibacterial film and wet wipe
CN104010724B (zh) 中性、稳定和透明的光催化二氧化钛溶胶
EP2671640A1 (en) Copper-and-titanium-containing composition and production method therefor
EP3511075B1 (en) Mixture of visible light-responsive photocatalytic titanium oxide fine particles, dispersion liquid thereof, method for producing dispersion liquid, photocatalyst thin film, and member having photocatalyst thin film on surface
TW200932342A (en) Antimicrobial membranes
CN115667149B (zh) 氧化铈的纳米粒子、包含氧化铈的纳米粒子的分散液、氧化剂、抗病毒剂及抗菌剂
CN111971076A (zh) 具有除臭性/抗菌性的表面层的内饰材料及其制造方法
EP3576798B1 (en) Method for the manufacture of functionalized fullerene metal nanocomposites
JP7830939B2 (ja) 酸化セリウムナノ粒子、分散液、抗酸化剤、酸化剤および酸化セリウムナノ粒子の製造方法
JP7771750B2 (ja) 酸化セリウムナノ粒子、酸化セリウムナノ粒子を含む分散液、抗酸化剤、酸化剤および酸化セリウムナノ粒子の製造方法
CA3019010A1 (en) Silane-based antimicrobial coatings and methods of making and using the same
Tassi et al. A detailed investigation of the microwave assisted phenylphosphonic acid modification of P25 TiO2
PL229207B1 (pl) Kompozycja w postaci płynu do pielęgnacji soczewek kontaktowych i materiałów medycznych
JPWO2021132628A5 (https=)
JP7740020B2 (ja) 酸化セリウムのナノ粒子、抗菌剤、抗ウイルス剤および酸化セリウムのナノ粒子の製造方法
KR20240067898A (ko) 산화세륨의 나노 입자, 분산액, 항바이러스제, 항균제, 수지 조성물, 수지 제품, 섬유 재료, 섬유 제품 및 산화세륨의 나노 입자를 제조하는 방법
EP4458804A1 (de) Verfahren zur herstellung eines gegenstandes, phenalen-1-on-verbindung sowie deren verwendung
CN118402970A (zh) 一种防晒剂及其制备方法与应用
JP2011020968A (ja) 水系防カビ剤
KR20250125973A (ko) 산화세륨의 나노 입자 및 그의 제조 방법
UA119626C2 (uk) ЗАСТОСУВАННЯ ЦИС-ТЕТРАГАЛОГЕНОДИ-<font face="Symbol">m</font>-КАРБОКСИЛАТІВ ДИРЕНІЮ(ІІІ) ЯК СПОЛУК З КАТАЛАЗНОЮ АКТИВНІСТЮ

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231108

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20231108

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241112

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20241223

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250227

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250507

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250520

R150 Certificate of patent or registration of utility model

Ref document number: 7694379

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150